USPTO serial 99885703
XENCOR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with XENCOR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Pasadena, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Virginia L. Carron
Virginia L. Carron Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.901 New York Avenue, NWWashington, DC 20001United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biochemicals, namely, antibody-based biologics for research and development; biochemicals, namely, antibody-based biologics and polypeptides for use in the manufacture of pharmaceuticals for the treatment of oncological and autoimmune diseases and disorders and infectious diseases; Reagents for medical research | ACTIVE | Jun 28, 2016 |
| 005 | Pharmaceutical preparations, namely, antibody-based biologics and proteins for the treatment of oncological and autoimmune diseases and disorders and infectious diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of oncological and autoimmune diseases and disorders and infectious diseases; antibody-based biologics for medical purposes; Therapeutic antibody-based biologics for human use for the treatment of oncological and autoimmune diseases and disorders and infectious diseases | ACTIVE | Jun 28, 2016 |
| 042 | Product development consulting in the fields of biotechnology and pharmaceuticals; product development for others in the fields of biotechnology and pharmaceuticals; Research and development services in the field of medical preparations; Research and development of antibody-based biologics; Research and development in the field of pharmaceuticals | ACTIVE | Jun 28, 2016 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 15, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 15, 2026 | NWAP | NEW APPLICATION ENTERED | — |